Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01189812. We help you review the study, but cannot decide medical eligibility.
CompletedNCT01189812
Safety and Efficacy of Citalopram for depression
This study is completed in the United States. It is testing safety and Efficacy of Citalopram for depression.
Personality disorders, Depression, ...DrugFrom 18 Years to 75 Years
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- San Diego, United States · Bellevue, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMarch 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 80
- Sponsor
- Columbia Northwest Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT01189812
- Official title
- A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Assess the Safety and Efficacy of Citalopram in Combination With Lithium or Placebo in the Treatment of Symptoms in Patients With Depressive Mood Disorders
Recruitment & locations
CompletedSan Diego · Bellevue
Registry details
Registry conditions (original wording)
Major Depressive Disorder; Dysthymia; Depression Not Otherwise Specified; Borderline Personality Disorder
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Columbia Northwest Pharmaceuticals.
Does this study involve medication?
Yes. The study involves medication, including Lithium Carbonate, Placebo and Citalopram.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as completed.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT03039192
Intranasal Esketamine for depression
This study is completed in the United States, in Bulgaria, in Estonia, .... It is testing intranasal Esketamine for depression.
CompletedNCT03097133
Intranasal Esketamine for depression
This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.
CompletedNCT05113771
Liafensine for Depression
This study is completed in the United States and in Canada. It is testing liafensine for Depression.